DH icon

Definitive Healthcare

3.14 USD
-0.16
4.85%
At close May 21, 4:00 PM EDT
After hours
3.14
+0.00
0.00%
1 day
-4.85%
5 days
-7.92%
1 month
25.10%
3 months
-36.18%
6 months
-26.12%
Year to date
-23.79%
1 year
-44.42%
5 years
-92.75%
10 years
-92.75%
 

About: Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

Employees: 782

0
Funds holding %
of 7,245 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

90% more call options, than puts

Call options by funds: $38K | Put options by funds: $20K

50% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 20

7% more funds holding

Funds holding: 127 [Q4 2024] → 136 (+9) [Q1 2025]

0.34% less ownership

Funds ownership: 90.88% [Q4 2024] → 90.54% (-0.34%) [Q1 2025]

2% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 44

32% less capital invested

Capital invested by funds: $431M [Q4 2024] → $295M (-$136M) [Q1 2025]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q4 2024] → 1 (-1) [Q1 2025]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$3
4%
downside
Avg. target
$3.20
2%
upside
High target
$3.40
8%
upside

2 analyst ratings

positive
0%
neutral
50%
negative
50%
Goldman Sachs
Kash Rangan
8%upside
$3.40
Neutral
Maintained
12 May 2025
Barclays
Saket Kalia
4%downside
$3
Underweight
Maintained
3 Mar 2025

Financial journalist opinion

Based on 4 articles about DH published over the past 30 days

Neutral
Seeking Alpha
1 week ago
Definitive Healthcare Corp. (DH) Q1 2025 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH ) Q1 2025 - Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Kevin Coop - CEO Rick Booth - CFO Casey Heller - SVP, Finance Conference Call Participants Jared Haase - William Blair Craig Hettenbach - Morgan Stanley David Grossman - Stifel George Hill - Deutsche Bank Jenny Shen - BTIG Operator Welcome to Definitive Healthcare's Q1 2025 Earnings Call. Later, we will conduct a question and answer session.
Definitive Healthcare Corp. (DH) Q1 2025 Earnings Call Transcript
Positive
Zacks Investment Research
1 week ago
Definitive Healthcare Corp. (DH) Beats Q1 Earnings and Revenue Estimates
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.08 per share a year ago.
Definitive Healthcare Corp. (DH) Beats Q1 Earnings and Revenue Estimates
Neutral
GlobeNewsWire
1 week ago
Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025
FRAMINGHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2025.
Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025
Neutral
GlobeNewsWire
3 weeks ago
Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its first quarter ended March 31, 2025, on Thursday, May 8, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast
Neutral
GlobeNewsWire
1 month ago
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted inducement awards. The Committee granted Jeff Moyer, Definitive Healthcare's new SVP of Growth and Sales Operations, an inducement award consisting of 364,432 time-based restricted stock units (“RSUs”), effective April 3, 2025. These awards were individually negotiated and granted as an inducement material to Mr. Moyer's respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
Neutral
GlobeNewsWire
2 months ago
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted inducement awards. The Committee granted Kate Hastings, Definitive Healthcare's new Chief Customer Officer an inducement award consisting of 172,414 time-based restricted stock units (“RSUs”) effective March 3, 2025 and granted Benjamin Graboske, Definitive Healthcare's new EVP, Technology, Engineering and Chief Data Officer an inducement award consisting of 1,018,330 time-based RSUs, effective March 3, 2025. Each of these awards was individually negotiated and was granted as an inducement material to Ms. Hastings' and Mr. Graboske's respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
Negative
Zacks Investment Research
2 months ago
New Strong Sell Stocks for March 4th
Teaser: AMRC, DH and AAON have been added to the Zacks Rank #5 (Strong Sell) List on March 4, 2025.
New Strong Sell Stocks for March 4th
Neutral
Seeking Alpha
2 months ago
Definitive Healthcare Corp. (DH) Q4 2024 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH ) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Rick Booth - Chief Financial Officer Conference Call Participants Jared Haase - William Blair Hanna Lee - Bank of America Jenny Shen - BTIG David Grossman - Stifel Maxi Ma - Deutsche Bank Johnathan McCary - Raymond James Craig Hettenbach - Morgan Stanley Jeff Garro - Stephens Operator Welcome to Definitive Healthcare's Q4 2024 Earnings Call. [Operator Instructions] I would like to now turn the call over to your host.
Definitive Healthcare Corp. (DH) Q4 2024 Earnings Call Transcript
Positive
Zacks Investment Research
2 months ago
Definitive Healthcare Corp. (DH) Q4 Earnings and Revenues Surpass Estimates
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.07 per share a year ago.
Definitive Healthcare Corp. (DH) Q4 Earnings and Revenues Surpass Estimates
Neutral
GlobeNewsWire
2 months ago
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024
FRAMINGHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended December 31, 2024.
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024
Charts implemented using Lightweight Charts™